BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imran M, Manzoor S, Parvaiz F. Predictive potential of IL-18 -607 and osteopontin -442 polymorphism in interferon-based therapy of HCV infection in the Pakistani population. Viral Immunol 2014;27:404-11. [PMID: 25198668 DOI: 10.1089/vim.2014.0044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Hussain MR, Hoessli DC, Fang M. N-acetylgalactosaminyltransferases in cancer. Oncotarget 2016;7:54067-81. [PMID: 27322213 DOI: 10.18632/oncotarget.10042] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
2 Wang M, Li JS, Ping Y, Li ZQ, Wang LP, Guo Q, Zhang Z, Yue DL, Wang F, Zhang TF, Islam MS, Zhang Y. The host HLA-A*02 allele is associated with the response to pegylated interferon and ribavirin in patients with chronic hepatitis C virus infection. Arch Virol 2015;160:1043-54. [PMID: 25666200 DOI: 10.1007/s00705-015-2361-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Imran M, Manzoor S, Azam S, Resham S. Genetic variant of IL28B rs12979860, as predictive marker of interferon-based therapy in Pakistani population. APMIS. 2015;123:342-349. [PMID: 25703417 DOI: 10.1111/apm.12365] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
4 Yang Y, Liu H. Association between interleukin-18 gene promoter (- 607C/A and - 137G/C) polymorphisms and chronic hepatitis C virus infections: A meta-analysis. Meta Gene 2015;5:21-31. [PMID: 26042207 DOI: 10.1016/j.mgene.2015.04.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
5 Zhu SL, Zhao Y, Hu XY, Luo T, Chen ZS, Zhang Y, Yang SH, Zhou L, Li LQ. Genetic polymorphisms -137 (rs187238) and -607 (rs1946518) in the interleukin-18 promoter may not be associated with development of hepatocellular carcinoma. Sci Rep 2016;6:39404. [PMID: 28000712 DOI: 10.1038/srep39404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
6 Huang W, Song L, Zhang J, Yan X, Yan H. Effects of miR-185-5p on replication of hepatitis C virus. Open Life Sci 2021;16:752-7. [PMID: 34395911 DOI: 10.1515/biol-2021-0067] [Reference Citation Analysis]
7 Abdelraheem WM, Hassuna NA, Abuloyoun SM, Abdel Ghany HM, Rizk HA, Abdelwahab SF. Interleukin-10.rs1800896 and Interleukin-18.rs1946518 gene polymorphisms could not predict the outcome of hepatitis C virus infection in Egyptian patients treated with pegylated interferon plus ribavirin. Arch Virol 2016;161:2473-80. [PMID: 27352267 DOI: 10.1007/s00705-016-2948-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 Guo P, Liu S, Sun X, Xu L. Association of TGF-ß1 polymorphisms and chronic hepatitis C infection: a Meta-analysis. BMC Infect Dis 2019;19:758. [PMID: 31470810 DOI: 10.1186/s12879-019-4390-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Ali M, Afzal S, Zia A, Hassan A, Khalil AT, Ovais M, Shinwari ZK, Idrees M. A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges. Medicine (Baltimore) 2016;95:e5327. [PMID: 27977575 DOI: 10.1097/MD.0000000000005327] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mansha S, Imran M, Shah AMUH, Jamal M, Ahmed F, Atif M, Saleem M, Safi SZ, Fatima Z, Bilal Waqar A. Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan. Viral Immunol 2017;30:366-70. [PMID: 28346804 DOI: 10.1089/vim.2016.0144] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]